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Abstract
DNAdouble-strandbreaks(DSBs)areaseriousthreattothecell,forifnotormiss-repaired,theycanleadtochromo-
somal aberration, mutation and cancer. DSBs in human cells are repaired via non-homologous DNA end joining
(NHEJ) and homologous recombination repair pathways. In the former process, the structure of DNA termini plays
an important role, as does the genetic constitution of the cells, through being different in normal and pathological
cells. In order to investigate the dependence of NHEJ on DSB structure in normal and cancer cells, we used
linearized plasmids with various, complementary or non-complementary, single-stranded or blunt DNA termini, as
well as whole-cell extract isolated from normal human lymphocytes, chronic myeloid leukemia K562 cells and lung
cancer A549 cells. We observed a pronounced variability in the efficacy of NHEJ reaction depending on the type of
ends. Plasmids with complementary and blunt termini were more efficiently repaired than the substrate with 3’ pro-
trudingsingle-strandends.ThehierarchyoftheeffectivenessofNHEJwasonaverage,fromthemosteffectivetothe
least,A549/normallymphocytes/K562.Ourresultssuggestthatthegeneticconstitutionofthecellstogetherwiththe
substrate terminal structure may contribute to the efficacy of the NHEJ reaction. This should be taken into account on
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The efficient repair of DNA double-strand breaks
(DSBs) is essential for the cell to maintain the integrity of
itsgenome.WhenDSBsarenotrepairedcorrectly,theycan
give rise to chromosomal breakage and translocation. In
vertebrate cells, this repair process has evolved in two dis-
tinct pathways: homologous recombination repair and non
homologous end-joining (NHEJ) (Valerie and Povirk,
2003), the latter relying on Ku (a heterodimer of Ku70
(69kDa),Ku80(86kDa)),DNA-PKcs(DNAproteinkinase
catalytic subunit), Artemis, Cernunnos, XRCC4 and DNA
ligase IV. In the first step of the NHEJ reaction, the hetero-
dimerofKu70/Ku80bindstoDNAends.Thisprocessacti-
vates DNA-PKcs by stabilizing its interaction with DNA
termini and recruiting another protein, either Artemis
(Less-Miller and Meek, 2003; Lieber et al., 2003) or Cer-
nunnos (Ahnesorg et al., 2006). This complex can trim the
DNA ends to make them ligatable. Many other proteins
with nuclease and polymerase activities may also contrib-
utetoprocessingDNAends.LigationbyligaseIV/XRCC4
heterodimer together with Cernunnos is the final step in
DSB repair via NHEJ. The requirement for DNA ligase IV
is imperative, as other DNA ligases are unable to substitute
for its function (Chen et al., 2000).
The structure of DNA ends plays an important role in
the fast and efficient repair of DSBs by NHEJ (Pastwa et
al., 2003; Wang et al. 2003). This structure implies, which
enzymatic activities will lead the repair process. Comple-
mentary and blunt ends can be joined by a simple ligation
(Smith et al., 2001). Only small subsets of complementary
ends are joined through end processing. Single-strand gaps
arefilledinbyDNApolymerasesbelongingtotheXfamily
- pol  , pol  , or terminal deoxytransferases (TdT) (Ma et
al.,2004).Thismechanismalsofunctionsintheprocessing
of non-complementary DNA ends, including 5’ protruding
single-strand (PSS) / blunt termini, requiring a primer for
the fill-in reaction. Priming is provided through the precise
alignmentofterminibyaproteincomplex(DNA-PK)asso-
ciated with juxtaposed DNA ends. On the other hand,
non-complementary DNA ends can also be joined after
small terminal deletion. The core NHEJ enzyme with nu-
clease activity is Artemis. Other nucleases which can be in-
volved in DSB repair via NHEJ are Werner syndrome
protein (WRN), an enzyme with nuclease and helicase ac-
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Short Communicationtivity and Mre11 subunit of the Mre11/Rad50/Nbs1 com-
plex (Yannone et al., 2001; D’amours and Jackson, 2002).
Mre11 has 3’-to-5’ dsDNA exonuclease and ssDNA endo-
nuclease activities. An additional NHEJ processing en-
zyme is the mammalian polynucleotide kinase (PNK).
PNKactsasa5’-kinase/3’-phosphatasetocreate5’-phos-
phate/3’-hydroxyltermini,whichareacrucialrequirement
for the ligation process. PNK is recruited to the repair com-
plexthroughinteractionswithXRCC4protein(Kochetal.,
2004). The ligation of mismatched and non-cohesive DNA
ends is facilitated by a recently discovered protein, Cer-
nunnos(Ahnesorgetal.,2006).CellslackingDNA-PKand
DNA ligase IV activity are incapable of efficiently repair-
ingDNADSBs(Wangetal.,2001).Thesecellsemployan-
other NHEJ pathway, which repairs DNA lesions with
20-30-foldslowerkinetics.TheslowerelementoftheDNA
rejoining system (known as B-NHEJ) is more error-prone
and DNA-PK-independent (Wang et al., 2003).
The efficient repair of a whole range of DSBs by
NHEJ and B-NHEJ depends on the accessibility of a pro-
tein machinery to damaged DNA, which is, at least in part,
determined by the structure of DNA termini. Normal and
cancer cells have different genetic constitutions and pre-
sumably a different ability to repair DSBs by end joining,
and they display a dissimilar sensitivity to drugs used in
cancer therapy which produce certain kinds of DSBs. To
elucidate the molecular mechanisms involved in the pro-
cessing of various DNA termini via NHEJ, we examined
the in vitro repair of linearized plasmid DNA containing
various ends, viz., blunt as well as complementary and
non-complementary 5’ or 3’ protruding single-strand
(PSS). We used the extracts from normal human lympho-
cytes, as well as two human cancer cell lines, namely
myeloid leukemia K562 and lung epithelial A549. We
chose these cell lines because they represented two differ-
enttypesoftumors.K562cellsarederivedfrombloodcan-
cer – they grow very quickly whereas A549 cells represent
solid tumors and grow relatively. Both cell lines display
different sensitivity to agents used in anticancer therapy –
ionizing radiation and topoisomerase II inhibitors, which
may be contingent on different DNA repair mechanisms
(Long et al., 1985; Chiron et al., 1992; Jeong et al., 2001;
Vens et al., 2002). In the A549 cell line, NHEJ protein ex-
pression and activities are normal (Long et al., 1985; Dig-
gle et al., 2003; Kasten-Pisula et al., 2007),whereas in
K562 cells the expression of such proteins may be down-
regulated (Deutsch et al., 2001). Nevertheless, the level of
mRNA in non-homologous end-joining genes was high
when compared to that in normal human lymphocytes
(Chiou et al., 2007). The data obtained may be of aid in in-
creasingchemotherapeuticefficiencywithdrugsproducing
specified termini of DNA double-strand breaks.
Peripheral blood lymphocytes (PBL) were obtained
from 10 young, healthy, non-smoking donors and isolated
by centrifugation in a density gradient of Ficoll (15 min,
230 g). After isolation, the lymphocytes were pooled and
their final concentration adjusted to 10
6 cells/mL by adding
the growth medium with phytohemagglutinin (PHA) to the
single cell suspension. The human myeloid leukemia cells
K562 and lung epithelial cancer cells A549 were main-
tained in exponential growth in RPMI 1640 supplemented
with 10% FBS and 1% streptomycin/penicillin. Cell viabil-
ity, measured by trypan blue staining, proved to be around
99%.
Cell extracts were prepared as previously described
(Pastwa et al., 2005). Briefly, the cells were harvested,
washed,pelletedtwiceinice-coldPBS(900g),andthenre-
suspended in a hypotonic lysis buffer (10 mM Hepes
[4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid],
pH 7.9, 60 mM KCl, 1 mM EDTA pH 8.0, 1 mM DTT) and
a protease inhibitor cocktail (according to manufacturer’s
instructions) (minimum 4-6 10
7 cells/0.5 mL of extraction
buffer). The cells were then lysed by three cycles of freeze-
thawing in a bath of dry ice/ethanol and in a 37 °C water
bath. We believe that we did not have any DNA, either mi-
tochondrial or nuclear, in our cell-extract, as this was clari-
fied by centrifugation at 15,000 g. The extract was then
stored at -70 °C until needed. Protein content was deter-
mined by the Bradford assay, using bovine serum albumin
as the standard (Bradford, 1976).
Linearized plasmid DNA (pUC19) was prepared by
digestion with restriction endonucleases (Fermentas) rec-
ognizingauniquesitewithinit.Toproducecomplementary
ends, the plasmid was digested with a single restriction en-
zyme HindIII. The substrates with non-complementary ter-
mini were prepared by means of combinations of two res-
triction enzymes (HindIII/EcoRI, KpnI/PstI, EcoRI/PstI,
EcoRI/HincII, and SphI/HincII) acting separately, and sin-
gle digestion with HincII, which produced blunt termini. In
the case of double digestion, the reaction with the first en-
zyme was checked by gel electrophoresis, where upon
linearized DNA was precipitated by ethanol and digested
with the second. DNA was purified from agarose gel with a
DNA extraction kit (Qiagen). Before the end joining assay
procedure, a small aliquot of the substrate DNA was sub-
jected to electrophoresis in agarose gel to estimate DNA
concentration.
End joining assay was performed as previously de-
scribed(Pastwaetal.,2001).Therepairreactionswerecar-
ried out in a total volume of 50 L, containing 50 mM Tris,
pH 8.0, 5 mM MgCl2, 1 mM ATP, 1 mM DTT, 5% poly-
ethyleneglycol 8000, a protease inhibitor cocktail, 100 ng
of substrate DNA and 15 g of proteins from A549, K562
or lymphocyte whole cell extract. Samples were incubated
at 17 °C for 16 h, because we observed the highest efficacy
of the NHEJ reaction at this temperature (Pastwa et al,.
2001). Repair was stopped by adding 0.4% SDS and incu-
bation at 65 °C for 15 min. DNA was recovered by extrac-
tion with phenol:chloroform (1:1 v/v) and ethanol precipi-
tation,using0.5gtRNAasacarrier.Repairproductswere
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1 h with Vistra Green, according to manufacturer’s instruc-
tions.Forquantification,gelswerescannedandbandswere
analyzed densitometrically using Quantity One 1-D analy-
sis software (Bio-Rad, Hercules, CA, USA).
All the values in this study represent the means  SD
forthreeseparateexperiments,eachperformedintriplicate.
One-way analysis of variance was used to evaluate the in-
fluence of the structure of DNA ends on the efficacy of
DNA repair. The differences between means were com-
pared using Scheffe’s multiple comparison test (SPSS Inc.,
Chicago, IL, USA).
To evaluate whether the ability of human cells to re-
pair DSBs by DNA end joining is affected by the structure
of the DNA ends, we used a plasmid-based in vitro end
joining assay. The plasmid DNA pUC19 has several single
restriction sites permitting a creation of double strand
breaks with various configurations of complementary and
non-complementarytermini(Figure1).Inordertoestimate
end-joining efficacy in whole cell extracts prepared from
normal and cancer cells, 100 ng of linearized plasmid DNA
was incubated with cellular extract. After 16 h the plasmid
DNA was recovered and the end joining reaction products
were densitometrically analyzed through agarose gel elec-
trophoresis. End-joining efficiency can be determined as a
percentage of multimers (dimers, trimers, etc.) in the origi-
nal linear DNA substrate. Typical pictures obtained from
agarosegelelectrophoresisofendjoiningreactionproducts
are shown in Figure 2. The results are displayed in Figure 3
and Table 1. Ligation efficiency in whole cell extracts pre-
pared from normal and cancer cells were compared.
Figure 3 and Table 1 show the ability to join different com-
plementaryandnon-complementaryendsbyextractsofhu-
man lymphocytes, K562 myeloid leukemia and A549 lung
epithelial cancer cells. All kinds of cells were able to repair
DNA lesions caused by restriction enzymes, but the effi-
ciency of DNA repair was different and was dependent on
the type of cells used for extract production and type of lin-
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Figure 1 - End structures of the DNA substrates used to determine NHEJ
efficacy in human cells. The restriction endonucleases used to create the
DNA termini are displayed together with the structure of the DNA ends
they generated.
Figure2-Atypicalresultofagarosegelelectrophoresisoftheproductsof
end-joining reactions after 16 h incubation of substrate pUC 19 DNA
plasmid linearized with HincII (A), EcoRI/PstI (B) and PstI (C), with cell
extractsfromhumanlymphocytes,K562andA549cells.A-lane1,0.5g
1 kb DNA; lane 2, HincII-cut DNA negative control; lanes 3-5, substrate
DNA + K562 cell extract; lanes 6-8, substrate DNA + human lymphocyte
cell extract; line 9-11, substrate DNA + A549 cell extract. B - lane 1, 0.5
g 1 kb DNA; lane 2, EcoRI/PstI-cut DNA negative control; lanes 3-5,
substrate DNA + K562 cell extract; lanes 6-8, substrate DNA + human
lymphocyte cell extract; lanes 9-11, substrate DNA + A549 cell extract.
C - lane 1, 0.5 g 1 kb DNA; lane 2, PstI-cut DNA negative control; lanes
3-4, substrate DNA + K562 cell extract; lanes 5-7, substrate DNA + hu-
man lymphocyte cell extract; lanes 8-10, substrate DNA + A549 cell ex-
tract.ear DNA ends generated by endonucleases, except for the
joining of incompatible 5’ overhang DNA substrates. The
mean of end joining for all types of investigated DNA ends
obtainedforextractsofK562cellswaslowerbyabout30%
than that obtained for A549 and human lymphocyte cells.
Human lymphocyte extract converted nearly 50% of com-
patible 5’ and 3’ linear DNA substrates to linear products
(dimers, trimers and high molecular weight products),
whereas in the remaining incompatible linear DNA sub-
strates, conversion was about 30%. The highest efficiency
of end joining with the A549 whole cell extract was
obtained for 3’ complementary overhangs. In general all
substrates containing 3’ overhangs were repaired very effi-
ciently (over mean value) by A549 whole cell extract, ex-
cept for 3’-blunt substrate. Our results show that the extract
from leukemic cells was more efficient in end-joining with
substratescontaining5’overhangsthanthosewith3’ends.
Pronounced variability in NHEJ efficiency, depend-
ing on end structure and cell type, was apparent. Only the
5’PSS/blunt termini were repaired with similar efficiency
in all cells. In general, single strands were joined with the
lowest efficacy. These data are different from results ob-
tainedinotherlaboratories.Smithetal.(2001),whenusing
a plasmid-based host-cell end-joining assay demonstrated
thatrepairefficacyofvariousDNAendsissimilar.Thedif-
ference may result from the fact that we compared end-
joining in vitro, whereas Smith and colleagues did so in
vivo. Moreover, SD values of the in vivo assay are high,
making it therefore difficult to estimate overall efficiency
of NHEJ activity in joining DNA ends with various config-
urations, and then arrive at final conclusions. We showed
that repair which does not require end processing, as in the
case of complimentary 5’ PSSs, 3’ PSSs and blunt/blunt, is
more effective than that of more complex DNA ends. This
is not surprising, since only DNA ligase is involved in the
joining of two complementary or blunt DNA ends, thereby
makingitlessenergy-andtime-consumingthanthejoining
of more complicated DNA termini, generally requiring a
multi-protein complex. To evaluate whether the efficacy of
repair was influenced by the sequence of the DNA termini,
we examined end joining reaction of linearized DNA sub-
strate containing blunt end with GC- and AT-rich se-
quences, but we did not observe any substantial difference
for DNA blunt ends generated by HincII (GTC|GAC),
SmaI (CCC|GGG) and SspI (AAT|ATT) enzymes (data not
shown).
We showed that the substrate with 3’ PSS non-
complementary ends was more efficiently joined by A549
cell extract, in contrast to remaining cell lines. These data
suggest that A549 cells may generate mechanisms respon-
sible for a very high efficient repair of DSBs containing 3’
PSS non-complementary ends. Repair of these DNA ter-
mini via NHEJ requires proteins with 3’ exonuclease activ-
ity. It seems that the A549 cells may be an appropriate
candidate for the study of molecular mechanisms of pro-
cessing of DNA ends in DSB repair via NHEJ, due to high
effectiveness of this process in these cells.
Our results demonstrate that the overall efficiency of
endjoininginhumanleukemiaK562cellextractwaslower
than in normal human lymphocytes and A549 cells. K562
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Table 1 - DNA end joining efficiency in human lymphocytes, K562 and A549 cells.
N. Enzyme DNA ends End joining efficiency [%]
Lymphocytes K562 A549
1 HindIII 5’ PSS/5’ PSS 55  5.6 40  1.3 31  3. 4
2 PstI 3’ PSS/3’ PSS 40  5.3 19  0.6 54  4.2
3 HincII blunt/blunt 25  3.8 40  3.5 31  2.7
4 HindIII/EcoRI 5’ PSS/5’ PSS 33  1.8 31  1.0 25  2.7
5 KpnI/PstI 3’ PSS/3’ PSS 33  0.8 17  2.2 47  1.6
6 EcoRI/PstI 5’ PSS/3’ PSS 21  4.9 17  2.9 40  1.6
7 EcoRI/HincII 5’ PSS/blunt 19  6.1 17  3.5 16  2.6
8 SphI/HincII 3’ PSS/blunt 16  3.6 4  1.1 11  1.6
Figure 3 - DNA end joining in human lymphocytes, and K562 and A549
cellsfordifferentcomplementaryandnon-complementarysubstrates.The
structure of analyzed substrate DNAs are schematically displayed below
the graph. Horizontal lines represent the mean for each type of cell used in
the experiment.cells express the BCR/ABL fusion oncogenic tyrosine
kinase that causes genomic instability and drug resistance
of human leukemia by modulating DNA repair (Blasiak et
al., 2002; Majsterek et al. 2002; Slupianek et al., 2002;).
Furthermore, in contrast to lymphocytes and A549, our
K562 cells do not express wild-type p53 tumor suppressor
protein, which is involved in DSB repair (Usuda et al.,
2003). Our current and previous data suggest that NHEJ
seems to be repressed by BCR/ABL in K562 cells (Pastwa
et al., 2005). Notably, Deutsch et al. (2001) demonstrated
down-regulation of the major mammalian DNA repair pro-
tein DNA-PKcs by BCR/ABL in BCR/ABL-positive
murine and human hematopoietic cells. Another report by
van Heemst et al. (2004) indicated that blunt ended DSBs
are efficiently rejoined in DNA-PKcs deficient cell lines.
These findings are in agreement with our results, by dem-
onstrating the highest repair efficiency in whole K562 ex-
tract for blunt-ended substrates. Contrary to our results,
Gaymes et al. (2002) showed that ligation efficiency of 5’
PSS complementary ends was increased 2-7 fold in
myeloid leukemia cells in comparison to normal peripheral
blood lymphocytes. We think that B-NHEJ activity in
BCR/ABL-positive leukemia cells is very intense, when
compared to normal cells. When DNA-PK dependent
NHEJislacking,cellsmustlaunchB-NHEJtorepairDSBs
andsurvive.Innormalcells,B-NHEJshouldbesilencedby
DNA-PK-dependent NHEJ, due to its more error-prone na-
ture and the longer time required in repairing DNA lesions.
Therefore, BCR/ABL-positive leukemia cells become ge-
netically unstable by including B-NHEJ in DNA DSB re-
pair. NHEJ activity in BCR/ABL-positive cells differs
from that in BCR/ABL-negative, this difference possibly
being related to the ratio of DNA-PK-dependent and -inde-
pendent NHEJ reactions.
It should be noted that similar studies have been car-
ried out with either intramolecular rejoining of re-circu-
larized plasmids (North et al. , 1990; Thacker et al., 1992;
Ganesh et al., 1993) or intermolecular rejoining of plas-
mids(Fairmanetal.,1992;Derbyshireetal.,1994;Nicolas
and Young, 1994; Nicolas et al., 1995). Intramolecular end
joining is not a good model for studying NHEJ activity,
since only small subset of substrate are rejoined by NHEJ
(Ohsaki et al., 2005). All remaining studies used a nuclear
extract as a source of NHEJ protein. We assumed that a
whole-cell extract would be a better source of NHEJ pro-
tein to examine activity of NHEJ in cell free system than a
nuclear extract, seeing that NHEJ protein, such as Ku, are
present in cytoplasm and are transported to nuclei in the
case of DNA double-strand break signaling (Nagasawa et
al., 1997). We also used the DNA extraction kit from
agarose gel to prepare DNA substrates used in this work.
Prepared this way, these substrates are free from contami-
nation by the small DNA fragments which are produced
when restriction enzymes cut plasmid vectors. Small DNA
fragments and uncut plasmid DNA remaining after diges-
tion of plasmid DNA by two restriction enzymes could in-
terfere in the NHEJ reaction and generate counterfeit end
results.Moreover,phenolusedinpreparationofNHEJsub-
strates in those studies can damage DNA (Claycamp,
1992). Thus substrates prepared by phenol extraction
should not be used in DNA repair assays that evaluate
NHEJactivity,astheyareatargetforBERinsteadofNHEJ
proteins.
Taken together, end-joining efficiency strongly de-
pends on the structure of DNA termini and the nature of the
cells. This, of course, is not surprising, but data on the re-
sponse to DSBs by particular cancer cells may be of assis-
tance when considering the use of drugs and/or irradiation
in cancer therapy, by making them more effective for can-
cer cells and less harmful for normal cells.
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